Tarafenacin

DB18810InvestigationalSmall molecule

Tarafenacin: Overview.

Mechanism: Pharmacologically active on Muscarinic acetylcholine receptor M3
Curator reviewed
Formula / weight: C₂₁H₂₀F₄N₂O₂ · 408.397 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyUXZDMXYRRQJIBJ-IBGZPJMESA-NSMILESFC1=CC=CC(=C1)N(CC1=CC(F)=C(F)C(F)=C1)C(=O)O[C@H]1CN2CCC1CC2

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Tarafenacin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.